Company Overview of The Multiple Myeloma Research Foundation, Inc
Key Executives for The Multiple Myeloma Research Foundation, Inc
Chief Executive Officer, President and Chief Operating Officer
Founder and Executive Chairman
Vice President of Communications
Chief Development and Marketing Officer
Compensation as of Fiscal Year 2014.
The Multiple Myeloma Research Foundation, Inc Key Developments
Multiple Myeloma Research Foundation, University of Torino and Adaptive Biotechnologies Work to Speed Novel Minimal Residual Disease Monitoring Technologies to Patients
Apr 14 15
The Multiple Myeloma Research Foundation (MMRF), in collaboration with the University of Torino (UofT) and Adaptive Biotechnologies, announced a collaboration to perform sequencing-based assessment of minimal residual disease (MRD) on hundreds of multiple myeloma (MM) patients over a five year period. The purpose of this initiative is to investigate a new approach to monitoring MRD. This collaboration, partially supported by Amgen, will be part of the INSIDE MM-1 study, led by Professor Antonio Palumbo from UofT. Professor Palumbo presented promising results of an earlier study at the 2013 American Society for Clinical Oncology (ASCO) annual meeting. This earlier study, funded by a 2010 Diagnostics Investment Award from the MMRF, set the stage for INSIDE MM-1, a groundbreaking, comparative, clinical disease monitoring trial. More than 400 newly diagnosed MM patients will be enrolled in INSIDE MM-1 and will receive a combination of carfilzomib and lenalidomide, followed by a bone marrow transplant with or without maintenance. Patients will be monitored for MRD using both flow cytometry and Adaptive Biotechnologies’ clonoSEQ MRD test at regular intervals from initial diagnosis for up to five years after initial treatment.
The Multiple Myeloma Research Foundation Appoints Wynton Marsalis to Honorary Board of Directors
Mar 10 15
The Multiple Myeloma Research Foundation (MMRF) announced that Managing and Artistic Director of Jazz at Lincoln Center, Wynton Marsalis has joined the MMRF Honorary Board.
The Multiple Myeloma Research Foundation, Inc Presents at 3rd Annual SACHS Cancer Bio Partnering and Investment Forum, Feb-23-2015 04:00 PM
Feb 22 15
The Multiple Myeloma Research Foundation, Inc Presents at 3rd Annual SACHS Cancer Bio Partnering and Investment Forum, Feb-23-2015 04:00 PM. Venue: The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St, 40th Floor (D Elevator Bank), New York, NY10007, United States. Speakers: Daniel Auclair, Vice President, Translational Research.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries